Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced Unresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
Latest Information Update: 31 Jan 2025
Price :
$35 *
At a glance
- Drugs Tislelizumab (Primary) ; Fluorouracil; Levofolinic acid; Oxaliplatin; Paclitaxel
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 31 Jan 2025 New trial record